Acrinova AB Series B (ACRI-B) — Capital Reinvestment Ratio
Acrinova AB Series B (ACRI-B) has a Capital Reinvestment Ratio of 1.00x as of March 2026, meaning it reinvests 1% of its operating cash flow (Skr51.65 Million) in capital expenditures (Skr51.65 Million). Check tangible equity quality of Acrinova AB Series B to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Acrinova AB Series B Capital Reinvestment Ratio (2014–2025)
This chart tracks Acrinova AB Series B's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Acrinova AB Series B generate cash.
Annual Capital Reinvestment Ratio for Acrinova AB Series B (2014–2025)
Year-by-year Capital Reinvestment Ratio for Acrinova AB Series B from 2014 to 2025. See Acrinova AB Series B free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | Skr337.73 Million | Skr86.50 Million | ▼ -67.8% |
| 2024 | 0.79x | Skr61.06 Million | Skr48.53 Million | ▼ -62.0% |
| 2023 | 2.09x | Skr71.23 Million | Skr148.92 Million | ▲ +1713.8% |
| 2021 | 0.12x | Skr79.90 Million | Skr9.21 Million | ▲ +55.3% |
| 2020 | 0.07x | Skr33.98 Million | Skr2.52 Million | ▼ -44.0% |
| 2019 | 0.13x | Skr10.57 Million | Skr1.40 Million | ▲ +44.4% |
| 2018 | 0.09x | Skr15.26 Million | Skr1.40 Million | ▲ +264.2% |
| 2017 | 0.03x | Skr25.46 Million | Skr642.00K | ▼ -74.3% |
| 2016 | 0.10x | Skr16.52 Million | Skr1.62 Million | ▼ -91.5% |
| 2014 | 1.16x | Skr41.33 Million | Skr47.85 Million | — |